Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill aims to keep AML in remission for older japanese patients

NCT ID NCT05197426

Ongoing Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether taking an oral chemotherapy drug (azacitidine) as maintenance therapy can help keep acute myeloid leukemia (AML) from returning in Japanese patients aged 55 and older who are already in remission. Participants will receive either the drug or a placebo, along with best supportive care. The goal is to see if the drug extends the time before relapse or death.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYELOID LEUKEMIA

Contacts and locations

Locations

  • Local Institution - 0001

    Maebashi, Gunma, 3710821, Japan

  • Local Institution - 0002

    Shinagawa, Tokyo, 141-8625, Japan

  • Local Institution - 0003

    Kashiwa-shi, Chiba, 2778577, Japan

  • Local Institution - 0004

    Sapporo, Hokkaido, 0640804, Japan

  • Local Institution - 0005

    Kamogawa, Chiba, 2968602, Japan

  • Local Institution - 0006

    Sagamihara-shi, Kanagawa, 2520375, Japan

  • Local Institution - 0007

    Yamagata, 990-9585, Japan

  • Local Institution - 0008

    Nagasaki, 8528511, Japan

  • Local Institution - 0009

    Toyoake, Aichi-ken, 470-1192, Japan

  • Local Institution - 0010

    Matsuyama, Ehime, 7900826, Japan

  • Local Institution - 0011

    Huntsville, Alabama, 35801, United States

  • Local Institution - 0012

    Isehara, Kanagawa, 2591193, Japan

  • Local Institution - 0013

    Yokohama, Kanagawa, 236-0004, Japan

  • Local Institution - 0014

    Ōgaki, Gifu, 503-8502, Japan

  • Local Institution - 0015

    Sendai, Miyagi, 9808574, Japan

  • Local Institution - 0016

    Fukuoka, Fukuoka, 810-8539, Japan

  • Local Institution - 0017

    Nagoya, Aichi-ken, 453-8511, Japan

  • Local Institution - 0018

    Fukuoka, 810-8563, Japan

  • Local Institution - 0019

    Kanazawa, Ishikawa-ken, 9208641, Japan

  • Local Institution - 0020

    Yoshida Gun, Fukui, 9101193, Japan

  • Local Institution - 0021

    Ōsaka-sayama, Osaka, 5898511, Japan

  • Local Institution - 0022

    Aomori, Aomori, 0308553, Japan

  • Local Institution - 0023

    Nagoya, Aichi-ken, 4668560, Japan

  • Local Institution - 0025

    Okayama, 7000914, Japan

  • Local Institution - 0026

    Osaka, Osaka, 5300012, Japan

  • Local Institution - 0027

    Fukuoka, 8120033, Japan

  • Local Institution - 0028

    Saitama, 330-8503, Japan

  • Local Institution - 0029

    Sumida Ku, Tokyo, 1308575, Japan

  • Local Institution - 0030

    Shinjuku-ku, Tokyo, 1600023, Japan

  • Local Institution - 0031

    Shimotsuke, Tochigi, 329-0498, Japan

  • Local Institution - 0032

    Bunkyo Ku, Tokyo, 1138677, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.